January 15, 2018 by Chain Drug Review
EnvisionRx, Health Dialog, Kermit Crawford, RediClinic, Rite Aid, Walgreens Boots Alliance
2018, Issue 01-15-2018, Issues, News

CAMP HILL, Pa. — Rite Aid Corp. president and chief operating officer Kermit Crawford said he’s confident the company “will succeed in building the new Rite Aid” following its $4.375 billion asset sale to Walgreens Boots Alliance (WBA). Under the deal, announced in September, Rite Aid is selling 1,932 stores, three distribution centers and related
January 15, 2018 by Geoff Walden and Chain Drug Review
AmerisourceBergen, Brian Nightengale, community pharmacy, Elevate Provider Network, Good Neighbor Pharmacy, independent pharmacies, J.D. Power U.S. Pharmacy Study
2018, Featured Articles, Issue 01-15-2018, Issues, Leading Headlines, News, Retail News

VALLEY FORGE, Pa. — AmerisourceBergen Corp.’s backing, combined with the entrepreneurship of independent pharmacies, has made the company’s Good Neighbor Pharmacy network an exemplar of high-touch service, says senior vice president of community and specialty pharmacy and Good Neighbor Pharmacy president Brian Nightengale. AmerisourceBergen’s support tools and personnel enhance the inherent ability of independents to
January 15, 2018 by Scot Meyer and Chain Drug Review
CVS Health, CVS Health's 2018 earnings outlook, David Denton, Larry Merlo, Red Oak
2018, Issue 01-15-2018, Issues, News
WOONSOCKET, R.I. — CVS Health executives expressed confidence in the company’s growth strategy earlier this month, and also noted that the recently passed tax overhaul packaged should boost its cash flow by an estimated $1.2 billion. The remarks came in a conference call following an announcement of CVS Health’s 2018 earnings outlook. CVS Health said
January 15, 2018 by Brian Bossetta
Bridge of Hope Fund, drug abuse, Fruth Pharmacy, Joe Manchin, Lynne Fruth, Shelley Moore Capito
2018, Issue 01-15-2018, Issues, News

POINT PLEASANT, W.Va. — Drug abuse, including the abuse of prescription painkillers, has reached epidemic proportions in the U.S., and Fruth Pharmacy, based here, is on the front lines of the fight, says Lynne Fruth, the company’s chairman and president. Along with West Virginia, Fruth has stores in Ohio and Kentucky, all of which have
January 15, 2018 by Geoff Walden and Chain Drug Review
ACA open enrollment, Affordable Care Act, health insurance, Lindsey Graham, Mitch McConnell
2018, Issue 01-15-2018, Issues, News
WASHINGTON — Nearly 9 million people signed up for health insurance in the Affordable Care Act’s latest open enrollment period, despite the Trump administration having cut its duration in half. The 8.8 million enrollees were only slightly fewer than the total in the last ACA open enrollment period, which, besides being longer, was much more
January 15, 2018 by Jeffrey Woldt and Chain Drug Review
Beth Husted, Jeffrey Woldt, Lewis Drug, Mark Griffin, NACDS Regional Chain Conference, National Association of Chain Drug Stores, Ritzman Pharmacy
2018, Issue 01-15-2018, Issues, Leading Headlines, Opinion

With the National Association of Chain Drug Stores gearing up for its annual NACDS Regional Chain Conference, which will run from February 4 through February 6 in Fort Lauderdale, Fla., it is a good moment to appraise that segment of the community pharmacy industry. Greatly reduced in number by the consolidation wave that has repeatedly
January 15, 2018 by Chain Drug Review
B. Douglas Hoey, Center for Medicare & Medicaid Innovation, Centers for Medicare & Medicaid Services, CMS-4182-P Medicare Program, community pharmacies, DIR fees, Medicare Part D, National Community Pharmacists Association, NCPA, PBM business model, pharmacy benefit managers
2018, Issue 01-15-2018, Issues, Opinion

WASHINGTON — In recent testimony before the House of Representatives Energy and Commerce Subcommittee on Health, National Community Pharmacists Association (NCPA) chief executive officer B. Douglas Hoey said pharmacists can drive better health outcomes and reduce costs, but first pharmacy benefit managers’ problematic business practices must be addressed through legislative and regulatory channels. As an